P1.16-63 the Value of Adjuvant Chemotherapy in Patients With Resected Stage IB Solid Predominant and Solid Non-Predominant Lung Adenocarcinoma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search